Summary

Understanding the underlying pathology of Parkinson's disease (PD) is critical in identifying the disease early and developing novel treatments. This article discusses the role of a-synuclein in PD, the extranigral pathology and preclinical detection of PD, as well as how the updated understanding of PD pathology explains its clinical phenotype